Industry News

Argentum Medical Signs Agreement with Sorbion for Distribution of Silverlon Wound Dressings
Medline and Devon Medical Products Form Exclusive U.S. Distribution Alliance to Provide Greater Access to Lymphedema and Arterial Compression Devices
Michael A. Griffith Named Executive Vice President Of inVentiv Health
Rogers and Lynch Introduce Bill to Withdraw FDA Approval of High-Dose Narcotic Painkiller Zohydro ER Rep. Harold Rogers (R-KY) News Release
Jay Crowley, Vice President of Unique Device Identification Practice at USDM Life Sciences, to Host UDI Compliance Webinar Crowley Developed Framework and Authored Key Requirements for FDA's UDI System
Repros Allowed to Conduct Phase 1 and 2 Clinical Studies of Low Dose Oral Proellex(R) in the Treatment of Uterine Fibroids and Endometriosis
Vansen Pharma Completes Acquisition of Consumer Health Products Entities
US BANS IMPORTS FROM SUN PHARMA'S GUJARAT PLANT
Jay Crowley, Vice President of Unique Device Identification Practice at USDM Life Sciences, to Host UDI Compliance Webinar Crowley Developed Framework and Authored Key Requirements for FDA's UDI System
Pierre Fabre Obtains FDA Approval to Market HemangeolTM for the Treatment of Infantile Hemangioma
FDA Advisory committee unanimously recommends Roche's HPV Test as primary screening tool for detection of women at high risk for cervical cancer
Argentum Medical Signs Agreement with Sorbion for Distribution of Silverlon� Wound Dressings
NICE: Better information needed on multiple myeloma drug
FDA Proposed Rule Would Restore Generic Drug Accountability
Alexander: FDA 'Off to a Fast Start' in Implementing New Law to Clarify Oversight of Compounding Pharmacies
Rogers and Lynch Introduce Bill to Withdraw FDA Approval of High-Dose Narcotic Painkiller Zohydro ER Rep. Harold Rogers (R-KY) News Release
Vansen Pharma Completes Acquisition of Consumer Health Products Entities
AstraZeneca Announces Progress on Global PARTHENON Clinical Trial Program with BRILINTA (ticagrelor) in High-Risk Cardiovascular Disease Patient Populations in Advance of American College of Cardiology Scientific Session
US Vascular Access Device Market Will Surpass $2 Billion by 2022 Growing Adoption of Premium-Priced Safety and Antimicrobial Devices Will Support Revenue Growth, According to Findings from Decision Resources Group
FDA Proposed Rule Would Restore Generic Drug Accountability
US Vascular Access Device Market Will Surpass $2 Billion by 2022 Growing Adoption of Premium-Priced Safety and Antimicrobial Devices Will Support Revenue Growth, According to Findings from Decision Resources Group
ISPE to Conduct Quality Metrics Pilot Program with FDA Participation -- Pilot to be designed and conducted with FDA input, will include broad and diverse industry representation --
Alexander: FDA 'Off to a Fast Start' in Implementing New Law to Clarify Oversight of Compounding Pharmacies
Alexander: FDA 'Off to a Fast Start' in Implementing New Law to Clarify Oversight of Compounding Pharmacies
FDA Proposed Rule Would Restore Generic Drug Accountability